Logout
 ACCP Evidence-Based
 Guidelines and Products
   Current Guidelines
   Guideline Review
   Ranking System
   Guidelines in
   Development
   Related Products
   Other HSP Publications
   ACCP Guideline
   Press Releases
 HSP Functions and
 Processes
 Guideline Development
 Processes
 Suggest a Future
 Guideline Topic
 Request for ACCP
 Endorsement of
 Guidelines
 HSP Calendar
 External Resources
 Contact HSP Staff

Health and Science Policy and Evidence-Based Medicine

Current Guidelines

The HSP Committee and its Guidelines Subcommittee review ACCP evidence-based clinical practice guidelines on an annual basis to determine if the recommendations in the guideline remain current. If there are new and significant studies that impact the recommendations, HSP must determine whether it would warrant an update of the guideline.

EVIDENCE-BASED CLINICAL PRACTICE GUIDELINES*
TITLE
MOST RECENT PUBLICATION DATE
RELATED PRODUCTS
REFERENCE
DATE OF ANNUAL REVIEW†
Antithrombotic and Thrombolytic Therapy: 8th Edition June 2008   8th Edition: Chest 2008;133 SSuppl 7th Edition: Chest 2004;126 Suppl 2009 1
Lung Cancer September 2007 2nd Edition:
Clinical Resource
1st Edition:
PDA Download
Patient Education Materials
Quick Ref Guide
2nd Edition Chest 2007;132: Suppl 1st Edition Chest 2003;123: Suppl NAP† 1
Pulmonary Arterial Hypertension June 2007 Clinical Resource Patient Education Materials Update of Medical Therapies Chest 2007; 131: 1917-28 Chest 2004;126 Suppl NAP† 2
Pulmonary Rehabilitation May 2007   Chest 2007;131;Suppl NAP† 1
Cough Management January 2006 Clinical Resource Patient Education Materials Chest 2006;129:Suppl 2007 3
Postoperative Atrial Fibrillation August 2005 Chest 2005;128:Suppl Chest 2001;122 Suppl 2007 2
Aerosol Therapy January 2005 Clinical Resource Patient Education Materials Chest 2005;127:335-371   2007 2
Weaning and Discontinuation of Ventilory Support December 2001 PDA Download Chest 2001;120:375S-396S 2007 2
Paraneumonic Effusions 2000 Chest 2000;118:1158-1171 2006 2
SYSTEMATIC REVIEWS AND CONSENSUS STATEMENTS‡
Systemic Hypertension
in Patients with Pulmonary Disease
2003 Chest 2003;123:222-243 NAP 5
Hypertension and Cardiovascular Disease with Sleep Disordered Breathing 2003 Chest 2003;123:244-260 NAP 5
Systemic Review: Sleep Apnea 2003 Chest 2003:124:1543-1579 NAP 5
Systemic Review: Inhaled Corticosteroid Use in Asthma 2003 Chest 2003;124:2329-2340 NAP 5
Systemic Review: Ventilator-Associated Pneumonia 2000 www.chestnet.org
PDA Download Quick Ref Guide
Chest 2000;117(4;Supp 2) NAP 5
The evidence-based practice guidelines published by The American College of Chest Physicians (“ACCP”) incorporate data obtained from a comprehensive literature review of the most recent studies available at the time of publication. Guidelines are intended for general information only, are not medical advice, and do not replace professional medical care and physician advice, which always should be sought for any specific condition. Furthermore, guidelines may not be complete or accurate because new studies that may have become available late in the process of guideline development may not be incorporated into any particular guideline before it is disseminated. ACCP and its officers, regents, governors, executive committee, members and employees (the “ACCP Parties”) disclaim all liability for the accuracy or completeness of a guideline, and disclaim all warranties, express or implied. Guideline users always are urged to seek out newer information that might impact the diagnostic and treatment recommendations contained within a guideline. The ACCP Parties further disclaim all liability for any damages whatsoever (including, without limitation, direct, indirect, incidental, punitive, or consequential damages) arising out of the use, inability to use, or the results of use of a guideline, any references used in a guideline, or the materials, information, or procedures contained in a guideline, based on any legal theory whatsoever and whether or not there was advice of the possibility of such damages.

* All ACCP evidence-based clinical practice guidelines can be accessed at
†All guidelines undergo annual review to determine current evidence beginning 1 year postpublication. The purpose is to determine whether or not the guideline remains current or is in need of revision.
‡Prior to 2004, the Health and Science Policy Committee allowed some consensus-based products to be developed in areas in which the evidence was very low. Since that time, these types of non-evidence-based products have been transferred to the ACCP NetWorks and Institutes for oversight.